Reply to Revolution

The political movement led by Harold Varmus as described in "A Science Publishing Revolution,"1 displays an unfortunate disregard for the study of dissemination, information science. The PubMed Central advocacy is storming about, armed with rhetoric and anecdotes rather than carefully gathered evidence. Moreover, they have carefully avoided admitting that the institutions with libraries could easily pay more than they do to support access to the most esoteric reports. Research universities are v

Written byAlbert Henderson
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

In spite of the passage of the National Science and Technology Policy, Organization, and Priorities Act of 1976, a law that mandated attention to dissemination, science policy directors have ignored academic libraries for 30 years. Library spending has not kept up with the growth of academic R&D since 1970. In spite of libraries being recognized as research overhead by Office of Management and Budget Circular A-21 (Principles for Determining Costs Applicable to Grants, Contracts, and Other Agreements with Educational Institutions), science agencies and universities ignore libraries as if they had no role in the preparation of proposals, authorship, and peer review.

Moreover, the prospect of a "closed-door invitation-only" meeting to get things done seems clearly anti-science. I would think that any member of the science community would prefer that policies be open and informed by reliable knowledge rather than oratory.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies